Laurion Capital Management LP Seagen Inc. Transaction History

Laurion Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $9.08 Million - $9.98 Million	48,399 New	48,399 $9.31 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $7.51 Million - $12.4 Million	-68,984 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $8.25 Million - $10.9 Million	68,984 New	68,984 $9.94 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.